Article
Prognostic and Therapeutic Implications of <i>BRAF</i> Mutations in Acute Myeloid Leukemia
2025-10-15
Abstract excerpt
Mutations in the RAS/MAPK signaling pathway are recurrent in acute myeloid leukemia (AML), primarily involving NRAS and KRAS . In contrast, mutations in the gene encoding an effector protein, BRAF, occur at relatively lower frequencies in AML and are associated with poor outcomes. To date, no comprehensive analysis has assessed the clinical and molecular characteristics of BRAF- mutated AML. In this study, we r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bdbfbdac-05e3-566c-8e90-ec33c1968b90
- DOI
- 10.1101/2025.10.14.682328
